Last update:

Vaccination news

Cardiology

Vaccination as a new form of cardiovascular prevention: An ESC Clinical Consensus Statement

A new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of vaccination in preventing cardiovascular events following various viral and bacterial infections.

Medical economics

Thimerosal discouraged in US flu vaccines, breaking with WHO guidance

A federal vaccine panel recently reshaped by US health secretary Robert F. Kennedy Jr., has voted to discourage the use of flu vaccines containing thimerosal, a mercury-based preservative. The decision marks a dramatic shift ...

Diseases, Conditions, Syndromes

Four new measles cases reported in Kentucky

Four new cases of measles have been reported in Kentucky this week, including three in one household in Woodford County.

Vaccination

COVID vaccine labels to warn of rare heart risk

The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.

Alzheimer's disease & dementia

Vaccine for RSV shown to reduce the risk of dementia

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. ...

Vaccination

CDC pulls vaccine slide after expert cites study doesn't exist

A presentation scheduled for a U.S. Centers for Disease Control and Prevention (CDC) vaccine meeting today claimed that a vaccine preservative could cause long-term brain effects—but the study it cited doesn't appear to ...

Pediatrics

US panel replaced under Trump backs new shot for kids

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new monoclonal antibody immunization against RSV, a common respiratory illness that is the leading cause of hospitalization ...

HIV & AIDS

HIV vaccine study uncovers powerful new antibody target

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies capable of blocking a ...

Medical economics

RSV immunization has saved Australia millions in hospital costs

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already resulted in 57% lower than expected hospitalizations in WA, saving the health system $6.2–6.9 million, ...

Diseases, Conditions, Syndromes

FDA requires trials of COVID shots for healthy kids and adults

U.S. regulators will no longer approve COVID booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.

Vaccination

US limits COVID boosters to over-65s or those at high risk

The United States will limit COVID-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine makers to run fresh clinical trials before offering shots to younger and healthier individuals, ...

Immunology

New B meningococcus vaccine shows promise in early-stage trial

The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting group B meningococcus (MenB), a significant cause of meningococcal disease worldwide, and establishes ...